欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Ebglyss	Human	lebrikizumab	Lebrikizumab	EMEA/H/C/005894	Almirall, S.A.	2023/11/16	Authorised
Finlee	Human	dabrafenib	dabrafenib mesilate	EMEA/H/C/005885	Novartis Europharm Limited	2023/11/15	Authorised
Aqumeldi	Human	enalapril maleate	Enalapril (maleate)	EMEA/H/C/005731	Proveca Pharma Limited	2023/11/15	Authorised
Herwenda	Human	trastuzumab	trastuzumab	EMEA/H/C/005769	Sandoz GmbH	2023/11/15	Authorised
Catiolanze	Human	latanoprost	Latanoprost	EMEA/H/C/005933	Santen Oy	2023/11/15	Authorised
Vanflyta	Human	quizartinib	quizartinib dihydrochloride	EMEA/H/C/005910	Daiichi Sankyo Europe GmbH	2023/11/06	Authorised
Jaypirca	Human	pirtobrutinib	pirtobrutinib	EMEA/H/C/005863	Eli Lilly Nederland B.V.	2023/10/30	Authorised
Zoonotic Influenza Vaccine Seqirus	Human	zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted)	A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b)	EMEA/H/C/006375	Seqirus S.r.l.	2023/10/09	Authorised
Degarelix Accord	Human	degarelix	degarelix acetate	EMEA/H/C/006048	Accord Healthcare S.L.U.	2023/09/29	Authorised
Tepkinly	Human	epcoritamab	epcoritamab	EMEA/H/C/005985	AbbVie Deutschland GmbH & Co. KG	2023/09/22	Authorised
Tyruko	Human	natalizumab	natalizumab	EMEA/H/C/005752	Sandoz GmbH	2023/09/22	Authorised
Tevimbra	Human	tislelizumab	tislelizumab	EMEA/H/C/005919	Beone Medicines Ireland Limited	2023/09/15	Authorised
Yesafili	Human	aflibercept	aflibercept	EMEA/H/C/006022	Biosimilar Collaborations Ireland Limited	2023/09/15	Authorised
Lyfnua	Human	gefapixant	gefapixant	EMEA/H/C/005476	Merck Sharp & Dohme B.V.	2023/09/15	Authorised
Orserdu	Human	elacestrant	elacestrant	EMEA/H/C/005898	Stemline Therapeutics B.V.	2023/09/15	Authorised
Tyenne	Human	tocilizumab	tocilizumab	EMEA/H/C/005781	Fresenius Kabi Deutschland GmbH	2023/09/15	Authorised
Inaqovi	Human	cedazuridine;decitabine	cedazuridine;decitabine	EMEA/H/C/005823	Otsuka Pharmaceutical Netherlands B.V.	2023/09/15	Authorised
Litfulo	Human	ritlecitinib	ritlecitinib tosilate	EMEA/H/C/006025	Pfizer Europe MA EEIG	2023/09/15	Authorised
Apretude	Human	cabotegravir	cabotegravir	EMEA/H/C/005756	ViiV Healthcare B.V.	2023/09/15	Authorised
Enrylaze	Human	crisantaspase	crisantaspase	EMEA/H/C/005917	Jazz Pharmaceuticals Ireland Limited	2023/09/15	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-